NCT05767398View on ClinicalTrials.gov

Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

58

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

April 28, 2023

Study Completion Date

April 28, 2023

Conditions

Healthy Volunteers

Interventions

DRUG

Zanubrutinib

Administered as a tablet or capsule

Trial Locations (1)

75247

Fortrea Clinical Research Unit, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors

lead

BeiGene

INDUSTRY

NCT05767398 - Bioequivalence of a Zanubrutinib Tablet Compared to Capsules in Healthy Adult Participants | Biotech Hunter | Biotech Hunter